Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Gene therapies for obesity revealed by Merck & Co., Baylor College of Medicine

March 16, 1998

SmithKline Beecham develops new anticonvulsants

March 13, 1998

Method of diagnosing Hodgkin's disease disclosed by cancer research institute

March 13, 1998

Neuronal SK(Ca) channel blockers prepared at U.K. university

March 13, 1998

Milkhaus receives patent protection for DNA treatment of respiratory disorders

March 13, 1998

SKB reveals new antiherpesvirus agents

March 13, 1998

Boehringer Ingelheim discloses new antiplatelet agents

March 13, 1998

Merck investigates antidiabetic/antiobesity agents

March 12, 1998

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...